Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telaprevir in Treatment-Naive Chronic Genotype 4 Hepatitis C
NCT00580801Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jan 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of telaprevir in chronic hepatitis C (CHC), sponsored by Janssen Pharmaceutical. Started Jan 2008; status: completed.
02
Drugs
telaprevir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT00580801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00580801.